Početna stranicaBBN • SWX
add
Bellevue Group AG
Preth. zaklj. cijena
14,00 CHF
Dnevni raspon
14,00 CHF - 14,25 CHF
Godišnji raspon
11,05 CHF - 24,15 CHF
Tržišna kapitalizacija
190,48 mil. CHF
Prosječna količina
11,19 tis.
P/E omjer
12,76
Prinos dividende
8,13 %
Glavno tržište vrijednosnica
SWX
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(CHF) | lip 2024.info | Godišnja promjena |
---|---|---|
Prihod | 18,41 mil. | −11,31 % |
Operativni troškovi | 13,73 mil. | −10,56 % |
Neto dohodak | 3,72 mil. | −7,22 % |
Neto profitabilnost | 20,18 | 4,61 % |
Zarada po dionici | — | — |
EBITDA | — | — |
Efektivna porezna stopa | 17,26 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(CHF) | lip 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 30,49 mil. | 100,63 % |
Ukupna imovina | 138,75 mil. | −4,69 % |
Ukupne obveze | 22,05 mil. | −24,81 % |
Ukupni kapital | 116,70 mil. | — |
Dionice u optjecaju | 13,20 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 1,58 | — |
Povrat imovine | 10,71 % | — |
Povrat kapitala | — | — |
Tok novca
Neto promjena novca
(CHF) | lip 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | 3,72 mil. | −7,22 % |
Gotovina od poslovanja | 3,65 mil. | 137,31 % |
Gotovina iz ulaganja | — | — |
Gotovina iz financiranja | −8,10 mil. | 45,85 % |
Neto promjena novca | −4,17 mil. | 83,13 % |
Slobodan tok novca | — | — |
Više
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Glavni izvršni direktor
Osnovano
1993
Web-lokacija
Zaposlenici
88